A citation-based method for searching scientific literature

Satoshi Kubo, Vanessa Smith, Maurizio Cutolo, Yoshiya Tanaka. Immunol Med 2018
Times Cited: 6







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases.
Vanessa Smith, Sam Beeckman, Ariane L Herrick, Saskia Decuman, Ellen Deschepper, Filip De Keyser, Oliver Distler, Ivan Foeldvari, Francesca Ingegnoli, Ulf Müller-Ladner,[...]. Rheumatology (Oxford) 2016
90
50

Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
H M A Hofstee, A Vonk Noordegraaf, A E Voskuyl, B A C Dijkmans, P E Postmus, Y M Smulders, E H Serné. Ann Rheum Dis 2009
96
50

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Ann Rheum Dis 2013
50


Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Martial Koenig, France Joyal, Marvin J Fritzler, André Roussin, Michal Abrahamowicz, Gilles Boire, Jean-Richard Goulet, Eric Rich, Tamara Grodzicky, Yves Raymond,[...]. Arthritis Rheum 2008
372
33

Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal.
Maurizio Cutolo, Karin Melsens, Sara Wijnant, Francesca Ingegnoli, Kristof Thevissen, Filip De Keyser, Saskia Decuman, Ulf Müller-Ladner, Yves Piette, Valeria Riccieri,[...]. Autoimmun Rev 2018
59
33

Timing of transition between capillaroscopic patterns in systemic sclerosis.
Alberto Sulli, Carmen Pizzorni, Vanessa Smith, Giuseppe Zampogna, Francesca Ravera, Maurizio Cutolo. Arthritis Rheum 2012
74
33

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Arthritis Rheum 2013
33

Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.
Slavica Pavlov-Dolijanovic, Nemanja S Damjanov, Roksanda M Stojanovic, Nada Z Vujasinovic Stupar, Dejana M Stanisavljevic. Rheumatol Int 2012
62
33


Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies.
Satoshi Kubo, Yasuyuki Todoroki, Shingo Nakayamada, Kazuhisa Nakano, Minoru Satoh, Aya Nawata, Yurie Satoh, Ippei Miyagawa, Kazuyoshi Saito, Vanessa Smith,[...]. Rheumatology (Oxford) 2019
15
33

Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
A Corrado, M Correale, N Mansueto, I Monaco, A Carriero, A Mele, R Colia, M Di Biase, F P Cantatore. Microvasc Res 2017
36
33

Nailfold Videocapillaroscopy in Systemic Sclerosis-related Pulmonary Arterial Hypertension: A Systematic Literature Review.
Vanessa Smith, Amber Vanhaecke, Els Vandecasteele, Miguel Guerra, Sabrina Paolino, Karin Melsens, Maurizio Cutolo. J Rheumatol 2020
15
33

Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis.
Vanessa Smith, Ariane L Herrick, Francesca Ingegnoli, Nemanja Damjanov, Rossella De Angelis, Christopher P Denton, Oliver Distler, Karinna Espejo, Ivan Foeldvari, Tracy Frech,[...]. Autoimmun Rev 2020
121
33

Pathophysiology of systemic sclerosis: current understanding and new insights.
Maurizio Cutolo, Stefano Soldano, Vanessa Smith. Expert Rev Clin Immunol 2019
120
33

Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity.
P Caramaschi, S Canestrini, N Martinelli, A Volpe, S Pieropan, M Ferrari, L M Bambara, A Carletto, D Biasi. Rheumatology (Oxford) 2007
92
33


Assessing microvascular changes in systemic sclerosis diagnosis and management.
Maurizio Cutolo, Alberto Sulli, Vanessa Smith. Nat Rev Rheumatol 2010
154
33

Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.
Francesca Ingegnoli, Roberta Gualtierotti, Annalisa Orenti, Tommaso Schioppo, Giovanni Marfia, Rolando Campanella, Claudio Mastaglio, Pier Luigi Meroni, Patrizia Boracchi. J Immunol Res 2015
10
16

Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study.
Tracy Frech, Dinesh Khanna, Boaz Markewitz, Geraldine Mineau, Richard Pimentel, Allen Sawitzke. Arthritis Rheum 2010
31
16

Raynaud's phenomenon: a proposal for classification.
E C LeRoy, T A Medsger. Clin Exp Rheumatol 1992
236
16


Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
M Nakano, Y Ohuchi, H Hasegawa, T Kuroda, S Ito, F Gejyo. J Rheumatol 2000
29
16

Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.
Frederick Wolfe, Michelle Petri, Graciela S Alarcón, John Goldman, Eliza F Chakravarty, Robert S Katz, Elizabeth W Karlson. J Rheumatol 2009
55
16

Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
M F Carpintero, L Martinez, I Fernandez, A C Garza Romero, C Mejia, Y J Zang, R W Hoffman, E L Greidinger. Lupus 2015
20
16

Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.
John D Pauling, Robyn T Domsic, Lesley A Saketkoo, Celia Almeida, Jane Withey, Hilary Jay, Tracy M Frech, Francesca Ingegnoli, Emma Dures, Joanna Robson,[...]. Arthritis Care Res (Hoboken) 2018
38
16


Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis.
G Sandqvist, P Wollmer, A Scheja, M Wildt, R Hesselstrand. Scand J Rheumatol 2018
4
25

Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.
H R Maricq, P H Carpentier, M C Weinrich, J E Keil, Y Palesch, C Biro, M Vionnet-Fuasset, M Jiguet, I Valter. J Rheumatol 1997
103
16

Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials.
Matthieu Roustit, Sophie Blaise, Yannick Allanore, Patrick H Carpentier, Evren Caglayan, Jean-Luc Cracowski. Ann Rheum Dis 2013
92
16


Treatment Algorithms for Systemic Sclerosis According to Experts.
Andreu Fernández-Codina, Kyle M Walker, Janet E Pope. Arthritis Rheumatol 2018
112
16

A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.
Jack D Wilkinson, Sarah A Leggett, Elizabeth J Marjanovic, Tonia L Moore, John Allen, Marina E Anderson, Jason Britton, Maya H Buch, Francesco Del Galdo, Christopher P Denton,[...]. Arthritis Rheumatol 2018
43
16

Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Fadumo Rirash, Paul C Tingey, Sarah E Harding, Lara J Maxwell, Elizabeth Tanjong Ghogomu, George A Wells, Peter Tugwell, Janet Pope. Cochrane Database Syst Rev 2017
33
16

Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.
David F Fiorentino, Karen Kuo, Lorinda Chung, Lisa Zaba, Shufeng Li, Livia Casciola-Rosen. J Am Acad Dermatol 2015
97
16

Role of cold and emotional stress in Raynaud's disease and scleroderma.
R R Freedman, P Ianni. Br Med J (Clin Res Ed) 1983
59
16

Surgical treatment of systemic sclerosis--is it justified to offer peripheral sympathectomy earlier in the disease process?
Arash Momeni, Sarah C Sorice, Antonia Valenzuela, David F Fiorentino, Lorinda Chung, James Chang. Microsurgery 2015
29
16


Prevalence of anti-endothelial cell antibodies in patients with pulmonary arterial hypertension associated with connective tissue diseases.
Meng-Tao Li, Jun Ai, Zhuang Tian, Quan Fang, Wen-Jie Zheng, Xue-Jun Zeng, Xiao-Feng Zeng. Chin Med Sci J 2010
6
16

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.
Nobuo Kuramoto, Koichiro Ohmura, Katsunori Ikari, Koichiro Yano, Moritoshi Furu, Noriyuki Yamakawa, Motomu Hashimoto, Hiromu Ito, Takao Fujii, Kosaku Murakami,[...]. Sci Rep 2017
5
20

Clinical practice. Raynaud's Phenomenon.
Fredrick M Wigley. N Engl J Med 2002
251
16

Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis.
John D Pauling, Elizabeth Reilly, Theresa Smith, Tracy M Frech. J Rheumatol 2019
17
16


Association of Raynaud's phenomenon with a polymorphism in the NOS1 gene.
Sabrina Munir, Maxim B Freidin, Susan Brain, Frances M K Williams. PLoS One 2018
9
16

Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
Hèctor Corominas, Vera Ortiz-Santamaría, Iván Castellví, Mireia Moreno, Rosa Morlà, Teresa Clavaguera, Alba Erra, Silvia Martínez-Pardo, Sergi Ordóñez, Pilar Santo,[...]. Rheumatol Int 2016
13
16

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.
Armen Yuri Gasparyan, Lilit Ayvazyan, Heather Blackmore, George D Kitas. Rheumatol Int 2011
335
16

Familial aggregation of primary Raynaud's disease.
R R Freedman, M D Mayes. Arthritis Rheum 1996
48
16

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
B Coleiro, S E Marshall, C P Denton, K Howell, A Blann, K I Welsh, C M Black. Rheumatology (Oxford) 2001
144
16

Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis.
H R Watson, R Robb, G Belcher, J J Belch. J Rheumatol 1999
29
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.